Tom Bologna ORCH's CEO has a good track record of taking a small bio-pharma companies to a higher stage; in some cases he raises their value and then oversees their integration into a larger group. He makes shareholders money. ORCH's business and Tom Bologna's strengths are a good match. I am looking for $8 within 18 months - maybe sooner.

I bought the dream of WiMax; if I had known Cramer was hot on it, I never would have bought it going up; I think it will come right, but it may take some time... once the disillioned Cramerites bail out...

Good technology; the poor management has been replaced and to my opinion the new management is preparing the company to be taken over. At what price it is hard to say - and when? But at currrent levels (under $9) the wait should be worthwhile